Dr. Katz comes to Montefiore and Einstein from both academic medicine and industry, where he has been most recently engaged in the biotech arena and drug development for several years. He served as CEO of Danube Pharmaceuticals and chief medical officer of both Fovea Pharmaceuticals and Eyetech, which brought the first medical therapy for macular degeneration to market. Prior to that, he had a distinguished career in academia, most recently as professor and chairman of the Department of Ophthalmology at the George Washington University School of Medicine. Over the course of his 25-year career, Dr. Katz has earned a reputation as a gifted clinician and teacher as well as an accomplished researcher. He also served as co-director of a joint fellowship in ophthalmologic drug development, regulation and trials co-sponsored by George Washington University and the U.S. Food and Drug Administration. As a neuro-ophthalmologist, Dr. Katz’s clinical expertise is in treatment of optic nerve diseases, unusual eye movements, and ocular manifestations of systemic diseases. He has joint appointments in the departments of ophthalmology, neurology, and neurosurgery at Montefiore and Einstein. Dr. Katz received his medical degree from Case-Western Reserve University School of Medicine. He completed an internship in medicine at Parkland Hospital in Dallas, served as a research staff associate in neuro-virology at the National Institutes of Health, completed a residency in neurology at Harvard University and an ophthalmology residency at Tufts-New England Medical Center. He completed fellowships at Harvard, at the National Hospital for Nervous Disease at Queen’s Square in London, and at the University of California, San Francisco (UCSF). Dr. Katz obtained an M.B.A. in finance and healthcare management from the University of Rochester’s Simon School of Business, and has served on the faculties of the University of California, San Diego, UCSF, and the University of Rochester. Dr. Katz has authored numerous articles published in peer reviewed journals, and has served on the board of directors for professional societies including the Ophthalmology Research and Education Foundation and the International Eye Foundation. He resides in New York City.
Neurology , Tardive Dyskinesia
Professor of Pathophysiology Marina Zueva graduated from the Lomonosov Moscow State University (Physiology of Higher Nervous Activity). She received her Ph.D. degree in 1980 and then the degree of Doctor of Biol Sci in 1997 from Moscow Helmholtz Research Institute of Eye Diseases. From 1973 to present time she works in the Department of Clinical Physiology of Vision at Moscow Helmholtz Research Institute of Eye Diseases. Current position - the Head of the Department. In 2017, she founded and became a General Director of the LTD “Center of Neurocognitive Technologies “Cognito”.” Marina Zueva is a member of International Society of Clinical Electrophysiology of Vision (ISCEV), European Association for Vision and Eye Research (EVER), European Society of Retina Specialists (EURETINA) and some other scientific Societies. She has published over 15 peer-reviewed papers in English and over 100 in Russian, 13 Chapters in the books (one – in English) and presented over 70 topics at international conferences. Research Topics: Basic and clinical physiology and electrophysiology of vision, neurophysiology; Age-related, developmental and neurodegenerative disorders of the visual system and brain, neurocognitive technologies in the diagnosis and treatment of diseases of the retina and brain.
Basic and clinical physiology and electrophysiology of vision, neurophysiology; Age-related, developmental and neurodegenerative disorders of the visual system and brain, neurocognitive technologies in the diagnosis and treatment of diseases of the retina and brain.
Dr. Federico Micheli is currently the Head of the Neurology Degree Department of the University of Buenos Aires and also Professor of Neurology, University of Buenos Aires. Dr. Federico Micheli has published 23 books and 48 chapters under his name and also holds 11 national journal publications and 120 international journals in the last 15 years.
Neurology , Tardive Dyskinesia
Professor LIU ZHEN-HUAN?is the deputy manager of the Affiliated Maternity and Child Care Hospital of Guangzhou University of Chinese Medicine. The director of the Rehabilitation Child of hospital, and the Doctoral tutor of the Guangzhou University of Chinese Medicine. Prof. Liu became one of the paediatricians who received the special state Council allowance in China in 1994, was given the title of the prominent contribute youth expert by the Healthy Ministry of China in 2002, Prof. Liu got the honour of “model worker in nationwide”. In addition, Prof. Liu is also the adjunct professor of The Chinese university of Hong Kong and Pharmacy and the Health Institute of Indonesian Ministry of Health. Professor Liu is famous Pediatric Neurology /Acupuncture Doctor in The world Prof. Liu has the experience of more than 30 years specializing in TCM- Western pediatrics studies and 20 years in rehabilitation for cerebral palsy. He founded the Rehabilitation Centre for Cerebral Palsy of the Affiliated Maternity and Child Care Hospital of Guangzhou University of Traditional Chinese Medicine?which is one of the world's renowned medical department. Since foundation, it has received more than 30,000 children with mental retardation and cerebral palsy from many countries, including China, the United States, Japan, the United Kingdom, New Zealand, Singapore, Poland, etc. Prof. Liu has also actively involved in the academic field. Since 1993, he has been giving seminars and academic exchange programs with world renowned scholars from Oxford University, Cambridge University, in the field of the application and assessment of the application of acupuncture treatment for brain and cerebral palsy rehabilitation in children throughout the world such as The United States, the United Kingdom, Spain, Australia, Norway, and so on.